Holen Sie sich die Stockscreener-App
8.705
0.40%
-0.045
Schlusskurs vom Vortag:
$8.75
Offen:
$8.71
24-Stunden-Volumen:
406.43K
Relative Volume:
0.36
Marktkapitalisierung:
$769.17M
Einnahmen:
$47.56M
Nettoeinkommen (Verlust:
$-156.83M
KGV:
-4.7568
EPS:
-1.83
Netto-Cashflow:
$-127.98M
1W Leistung:
+5.38%
1M Leistung:
+8.80%
6M Leistung:
-32.55%
1J Leistung:
-51.50%
1-Tages-Spanne:
$8.665
$8.90
1-Wochen-Bereich:
$8.185
$8.90
52-Wochen-Spanne:
$6.38
$19.09
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Firmenname
Avadel Pharmaceuticals Plc
Sektor
Telefon
636-449-1830
Adresse
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Vergleichen Sie AVDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
8.715 | 769.17M | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
155.98 | 65.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 46.99B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.28 | 45.96B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.63 | 15.27B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
300.22 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-12 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-05 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-05 | Bestätigt | Needham | Buy |
| 2024-03-05 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2022-11-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-28 | Fortgesetzt | Craig Hallum | Buy |
| 2022-05-26 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2020-07-21 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-03 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Eingeleitet | Stifel | Buy |
| 2020-02-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-30 | Eingeleitet | Craig Hallum | Buy |
| 2019-06-14 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
Alle ansehen
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
UBS Adjusts Avadel Pharmaceuticals Price Target to $12 From $14, Maintains Buy Rating - marketscreener.com
LPL Financial LLC Purchases 10,072 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
JPMorgan Chase & Co. Has $1.17 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (AVDL)’s Market Momentum: Closing Strong at 8.60, Up 3.49 - DWinneX
Avadel Pharmaceuticals plc (AVDL)’s stock performance: a year in review - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
AVDL Stock Sees Surge of Approximately 5.06% in Last Five Days - knoxdaily.com
Avadel Pharmaceuticals plc (AVDL) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Geode Capital Management LLC Acquires 10,886 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Russell Investments Group Ltd. Acquires 11,350 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Alliancebernstein L.P. Boosts Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Insider Buying: Palczuk Linda, Avadel Pharmaceuticals plc [AVDL] Director invested 5,000 shares - knoxdaily.com
Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience - TradingView
Equities Analysts Offer Predictions for AVDL Q1 Earnings - Defense World
Equities Analysts Set Expectations for AVDL Q2 Earnings - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability - Yahoo Finance
Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Set To Breakeven - simplywall.st
Vanguard Group Inc. Buys 90,147 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Needham & Company LLC Reiterates Buy Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World
Avadel Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Stock Position Decreased by Corebridge Financial Inc. - Defense World
Avadel reports steady demand and patent lawsuits By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals updates at healthcare conference By Investing.com - Investing.com South Africa
Avadel Highlights Improved Demand for LUMRYZ at Conference - TipRanks
Avadel Pharmaceuticals updates at healthcare conference - Investing.com
Avadel Pharmaceuticals Projects 'Sustainable' Positive Cash Flow in 2025 - MarketScreener
Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference - The Manila Times
Avadel reports steady demand and patent lawsuits - Investing.com
KLP Kapitalforvaltning AS Purchases New Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Sold by Commonwealth Equity Services LLC - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Rating of “Buy” by Analysts - Defense World
AVDL Stock Sees Decline of Approximately -8.69% in Last Five Days - knoxdaily.com
Teacher Retirement System of Texas Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference - The Manila Times
When (AVDL) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Swiss National Bank Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Announces Publication of Manuscripts on Narcolepsy Management in CNS Drugs Supplement - Nasdaq
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians - The Manila Times
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with - EIN News
Is Avadel Pharmaceuticals plc (AVDL) worth investing in despite its overvalued state? - uspostnews.com
Atria Investments Inc Has $281,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights By Investing.com - Investing.com UK
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - simplywall.st
Arizona State Retirement System Acquires 2,938 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Insider Trading At Avadel Pharmaceuticals plc (NASDAQ: AVDL): What Did We Note? - Stocks Register
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World
Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avadel Pharmaceuticals Plc-Aktie (AVDL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
| Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
| Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
| Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
| Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):